Sustained Benefit of Short-Term Levodopa Treatment on Inner Retinal Function in Patients With Diabetes.

Although OP 2 IT did not reach statistical significance at baseline in this re-analysis, a similar trend was observed, with the DM + L-DOPA group exhibiting greater delays compared to the DM group (DM: n = 6, OP 2 IT = 42.90 ± 2.12 ms; DM + L-DOPA: n = 14, OP 2 IT = 46.80 ± 3.61 ms; Wilcoxon rank-sum exact test, P = 0.099; Fig. 2 C).

also in 111,027 other papers